Medical Countermeasures UK Opens Moderna mRNA Vaccine Centre in Oxfordshire and Launches £50 Million Life-Sciences FundGlobal Biodefense StaffSeptember 29, 2025
Contracts + Grants U.S. Expands Investments in Biodefense Preparedness Through New Medical Countermeasure ContractsGlobal Biodefense StaffSeptember 23, 2025
Pathogens New Study Reveals Key to Marburg and Ebola Virus Assembly, Opening Door to Broad-Spectrum AntiviralsGlobal Biodefense StaffSeptember 23, 2025
Emergent BioSolutions Partners with BARDA to Expedite Development of Plasma-Derived Therapy for COVID-19 Medical Countermeasures April 2, 2020 …
Celularity Announces FDA Clearance of IND Application for CYNK-001 in Coronavirus, First in Cellular Therapy Medical Countermeasures April 2, 2020 …
Tests in Engineered Human Tissues Show hrsACE2 Drug Blocked Early Stages of SARS-CoV-2 Infection Medical Countermeasures April 2, 2020 …
Hydroxychloroquine and Azythromycine Combo Treatment for COVID Can Raise Risk for Dangerous Abnormal Heart Rhythms Medical Countermeasures April 2, 2020 …
JPEO-CBRND, BARDA Partner with SAb Biotherapeutics to Develop COVID-19 Therapeutic Medical Countermeasures April 1, 2020 …
Sanofi and Translate Bio Team Up to Develop Novel Coronavirus mRNA Vaccine Medical Countermeasures March 28, 2020 …
Mapping Risks to the Drug Supply Chain During COVID-19 Pandemic: Critical Shortages Likely in U.S. Medical Countermeasures March 28, 2020 …
5 Questions Answered About Chloroquine: An Unproven Drug Against Coronavirus Medical Countermeasures March 25, 2020 …
WUSTL Researchers Investigate Transfusion of Antibodies from Recovered Patients’ as COVID-19 Treatment Medical Countermeasures March 25, 2020 …
FDA Allows Emergency Use of Investigational Convalescent Plasma for Critical COVID-19 Patients Medical Countermeasures March 24, 2020 …
Why Don’t We Have Drugs to Treat COVID-19 and How Long Will It Take to Develop Them? Medical Countermeasures March 21, 2020 …
Ridgeback Biotherapeutics and DRIVE Partner to Develop Clinical Stage Coronavirus Treatment Medical Countermeasures March 19, 2020 …
Lopinavir-Ritonavir Does Not Offer Substantial Benefit in Severe COVID-19 Medical Countermeasures March 18, 2020 …
PharmaJet Receives $9.6 Million Dollar Award to Support Next-Generation Needle-Free Delivery Devices Medical Countermeasures March 17, 2020 …
Novel High-Density Microarray Patch Can Deliver Vaccines Directly to the Skin Medical Countermeasures March 17, 2020 …
Hotel Influenza: Research Heats Up on Universal Flu Vaccines Medical Countermeasures March 17, 2020 …
Regeneron and Sanofi Begin Global Clinical Trial for Use of Sarilumab in Severe COVID-19 Patients Medical Countermeasures March 16, 2020 …
